Atossa Therapeutics CEO Discusses Breast Density Data - Noble Capital Markets Healthcare Conference

For the full presentation and in-depth analysis, watch the complete video at https://channelchek.cc/3w5uWbk

Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company’s drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Noble Capital Markets Emerging Growth Virtual Healthcare Conference

Видео Atossa Therapeutics CEO Discusses Breast Density Data - Noble Capital Markets Healthcare Conference канала channelchek